Insider · CIK 0002005986
Christopher M. Murphy
Files at ANAB (ANAPTYSBIO, INC), THRD (Third Harmonic Bio, Inc.). First filing -, latest -.
In brief
Christopher M. Murphy files SEC Form 4 as CFO at ANAB (ANAPTYSBIO, INC), and also at THRD (Third Harmonic Bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christopher M. Murphy has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | ANAB ANAPTYSBIO, INC | AGrant or award Restricted Stock Unitsderivative | +25,765 | $0.00 | $0 | 25,765 | May 13, 2026 |
| Aug 11, 2025 | THRD Third Harmonic Bio, Inc. | JOther Restricted Stock Unitderivative | -47,500 | $0.00 | $0 | 0 | Aug 14, 2025 |
Questions about Christopher M. Murphy
Answered from the filings on this page, as of the latest one.
Is Christopher M. Murphy buying or selling?
Christopher M. Murphy has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christopher M. Murphy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher M. Murphy has 0.
Where does Christopher M. Murphy file Form 4?
Christopher M. Murphy has filed Form 4 at ANAB (ANAPTYSBIO, INC) as Chief Financial Officer; THRD (Third Harmonic Bio, Inc.) as Chief Financial & Bus. Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.